Federal Register / Vol. 82, No. 177 / Thursday, September 14, 2017 / Notices 43237 

Power Auxiliary Stations in the 

Repurposed 600 MHz Band and 600 

MHz Duplex Gap, Expanding the 

Economic and Innovation Opportunities 

of Spectrum Through Incentive 

Auctions, Order, GN Docket No. 14–166, 

ET Docket No. 14–165, and GN Docket 

No. 12–268. In this Order, the Consumer 

and Governmental Affairs Bureau, 

Wireless Telecommunications Bureau, 

and the Office of Engineering and 

Technology provided the specific 

language that must be used in the 

consumer disclosure required by the 

Commission in its 2015 Wireless 

Microphones Report and Order, as set 

forth in Sections 15.37(k) and 74.851(l) 

of the Commission’s rules. As the Order 

explains, the consumer disclosure 

requirement is applicable to persons 

who manufacture, sell, lease, or offer for 

sale or lease, wireless microphone or 

video assist devices to the extent that 

these devices are capable of operating 

on the specific frequencies associated 

with the 600 MHz service band (617–652 

MHz/663–698 MHz). This disclosure 

also informs consumers that, consistent 

with the Commission’s decision in the 

2015 Wireless Microphones Report and 

Order, wireless microphone users must 

cease any wireless microphone 

operations in the 600 MHz service band 

no later than July 13, 2020, and that in 

many instances they may be required to 

cease use of these devices earlier if their 

use has the potential to cause harmful 

interference to 600 MHz service 

licensees’ wireless operations in the 

band. 

Federal Communications Commission. 

Marlene H. Dortch, 

Secretary. Office of the Secretary. 

[FR Doc. 2017–19532 Filed 9–13–17; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meeting 

AGENCY: Federal Election Commission. 

DATE AND TIME: Tuesday, September 19, 

2017 at 10:00 a.m. and its continuation 

at the conclusion of the open meeting 

on September 20, 2017. 

PLACE: 999 E Street NW., Washington, 

DC. 

STATUS: This meeting will be closed to 

the public. 

ITEMS TO BE DISCUSSED: Compliance 

matters pursuant to 52 U.S.C. 30109. 

* * * * * 

PERSON TO CONTACT FOR INFORMATION: 

Judith Ingram, Press Officer, Telephone: 

(202) 694–1220. 

Laura E. Sinram, 

Deputy Secretary of the Commission. 

[FR Doc. 2017–19672 Filed 9–12–17; 4:15 pm] 

BILLING CODE 6715–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than October 11, 

2017. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Rigler Investment Company, New 

Hampton, Iowa; to acquire the voting 

shares of Green Circle Investments, Inc., 

Clive, Iowa and thereby indirectly 

acquire Peoples Trust and Savings Bank, 

Clive, Iowa. 

Board of Governors of the Federal Reserve 

System, September 11, 2017. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2017–19546 Filed 9–13–17; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y, (12 

CFR part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than October 11, 2017. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Associated Banc-Corp, Green Bay, 

Wisconsin; to merge with Bank Mutual 

Corporation, Milwaukee, Wisconsin and 

thereby indirectly acquire Bank Mutual, 

Brown Deer, Wisconsin and thereby 

engage in operating a savings 

association, pursuant to section 

225.28(b)(4)(ii) of Regulation Y. 

Board of Governors of the Federal Reserve 

System, September 11, 2017. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2017–19547 Filed 9–13–17; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
43238 Federal Register / Vol. 82, No. 177 / Thursday, September 14, 2017 / Notices 

ACTION: Notice of meeting. 

SUMMARY: In accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Advisory Committee on Immunization 

Practices (ACIP). 

This meeting is open to the public, 

limited only by the space available. 

Time will be available for public 

comment. The public is welcome to 

submit written comments in advance of 

the meeting. Comments should be 

submitted in writing by email to the 

contact person listed below. The 

deadline for receipt is October 11, 2017. 

Written comments must include full 

name, address, organizational 

affiliation, email address of the speaker, 

topic being addressed and specific 

comments. Written comments must not 

exceed one single-spaced typed page 

with 1-inch margins containing all items 

above. Only those written comments 

received 10 business days in advance of 

the meeting will be included in the 

official record of the meeting. Public 

comments made in attendance must be 

no longer than 3 minutes and the person 

giving comments must attend the public 

comment session at the start time listed 

on the agenda. Time for public 

comments may start before the time 

indicated on the agenda. The meeting 

will be webcast live via the World Wide 

Web; for instructions and more 

information on ACIP please visit the 

ACIP Web site: http://www.cdc.gov/ 

vaccines/acip/index.html. 

DATES: The meeting will be held on 

October 25, 2017, 8:00 a.m. to 6:00 p.m., 

EDT, and October 26, 2017 8:00 a.m. to 

3:15 p.m. EDT. 

ADDRESSES: 1600 Clifton Road NE., 

Atlanta, GA 30329, CDC, Tom Harkin 

Global Communications Center, Kent 

‘Oz’ Nelson Auditorium. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, CDC, NCIRD; 

email: ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters to be Considered: The agenda 

will include discussions on adult 

immunization schedule, child/ 

adolescent immunization schedule, 

influenza vaccines, anthrax vaccine, 

Japanese encephalitis vaccines, hepatitis 

vaccines, herpes zoster vaccines, human 

papillomavirus vaccines, mumps 

vaccine, pneumococcal vaccines, 

respiratory syncytial virus vaccine and 

immunization safety update. A 

recommendation vote is scheduled for 

adult immunization schedule, child/ 

adolescent immunization schedule, 

hepatitis vaccines and herpes zoster 

vaccines. A Vaccines for Children vote 

is scheduled for hepatitis vaccines. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–19497 Filed 9–13–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting. 

The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 

5 U.S.C., and the Determination of the 

Director, Management Analysis and 

Services Office, CDC, pursuant to Pub. 

L. 92–463. 

Name of Committee: Safety and 

Occupational Health Study Section (SOHSS), 

National Institute for Occupational Safety 

and Health (NIOSH). 

Date: October 31–November 1, 2017. 

Time: 8:00 a.m.–5:00 p.m., CST. 

Place: The Wit Hotel, 201 North State 

Street, Chicago, Illinois 60601. 

Agenda: The meeting will convene to 

address matters related to the conduct of 

Study Section business and for the study 

section to consider safety and occupational 

health-related grant applications. 

For Further Information Contact: Price 

Connor, Ph.D., NIOSH Health Scientist, CDC 

2400 Executive Parkway, Atlanta, Georgia 

30345, (404) 498–2511, spc3@cdc. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–19500 Filed 9–13–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting. 

The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 

5 U.S.C., and the Determination of the 

Director, Management Analysis and 

Services Office, CDC, pursuant to Public 

Law 92–463. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—PAR 13–129, NIOSH 

Member Conflict Special Emphasis Panel. 

Date: October 25, 2017. 

Time: 1:00 p.m.–5:00 p.m., EDT. 

Place: Teleconference. 

Agenda: The meeting will include the 

initial review, discussion, and evaluation of 

applications received in response to PAR 13– 

129, NIOSH Member Conflict Special 

Emphasis Panel. 

For FuRther Information Contact: Nina 

Turner, Ph.D. Scientific Review Officer, CDC, 

1095 Willowdale Road, Morgantown, West 

Virginia 26506, (304) 285–5976, nxt2@

cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 


asabaliauskas on DSKBBXCHB2PROD with NOTICES